Hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection: A patient reported outcomes study
Autor: | Kimberly J. Chin, Paul T. Finger, Gaurav Garg, Ankit Singh Tomar, Anthony Fam |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
intravitreal
Hypochlorous acid medicine.drug_class antisepsis medicine.medical_treatment medicine.disease_cause chemistry.chemical_compound betadine® Endophthalmitis Antiseptic lcsh:Ophthalmology comfort Medicine Humans Patient Reported Outcome Measures Patient Comfort Patient comfort pro business.industry Washout medicine.disease Ophthalmology Artificial tears chemistry quality of life lcsh:RE1-994 Anesthesia Intravitreal Injections Anti-Infective Agents Local hypochlorous acid Original Article prophylaxis Irritation hocl business |
Zdroj: | Indian Journal of Ophthalmology, Vol 68, Iss 11, Pp 2439-2444 (2020) Indian Journal of Ophthalmology |
ISSN: | 1998-3689 0301-4738 |
Popis: | Purpose: Current ocular antiseptic practice for intravitreal injection (IVI) employs 5% povidone–iodine (Betadine®) drops which frequently cause ocular discomfort and prolonged irritation. In an effort to improve comfort while maintaining efficacy, we studied a hypochlorous acid (HOCL 0.01%) spray washout prior to injection. Methods: Patients had received a minimum of 3 IVIs prepared with Betadine® antisepsis prior to entry in this study. Their subsequent IVIs were prepared with Betadine® followed by HOCL 0.01% washout. Facets of comfort were measured by a Likert-scaled questionnaire to compare their experiences after IVI. Results: Thirty-seven participants were enrolled. Addition of HOCL 0.01% spray after Betadine® reduced the duration of discomfort (P = 0.001) and need for artificial tears postinjection (P = 0.003). It improved their reported quality of life (P = 0.04) and sleep (P = 0.01). There were neither HOCL-related side effects nor endophthalmitis during this study. Conclusion: Topical HOCL 0.01% spray after topical Betadine® antisepsis significantly improved patient comfort following IVIs. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |